InMed Pharmaceuticals (INM) vs Exicure (XCUR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
InMed Pharmaceuticals is the larger company by market cap ($7.5 million vs $6.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INM | XCUR |
|---|---|---|
| Share price | $1.36 | $1.05 |
| Market cap | $7.47M | $6.87M |
| 1-day change | +2.26% | +3.96% |
| EPS (TTM) | $-2.84 | $-1.38 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.33 | $9.48 |
| 52-week low | $0.575 | $0.936 |
| Distance from 52-week high | -41.63% | -88.92% |
| Average volume | 928.44K | 399.32K |
| Shares outstanding | 5.49M | 6.55M |
| Employees | 6 | 1 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About InMed Pharmaceuticals
INM stock →InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
About Exicure
XCUR stock →Exicure, Inc. does not have significant operations.
Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees
INM vs XCUR FAQ
Which is bigger, InMed Pharmaceuticals or Exicure?
InMed Pharmaceuticals (INM) is larger, with a market capitalization of $7.47M compared with $6.87M for Exicure (XCUR).
Are InMed Pharmaceuticals and Exicure in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.